Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-6.72%
+35.16%
+1.40%
+4.07%
+0.45%
IOBT
IO Biotech
$0.48
Login to see IO Biotech (IOBT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Earnings are forecast to grow
Chart
$1.8 (-73.33%)
$1.7 (-71.76%)
$1 (-52.00%)
$1.23 (-60.98%)
IOBT has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Price under $5
High volatilty
IOBT overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Loss widens YoY
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
IOBT Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
IOBT Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayIOBT Earnings
The TTM reflects 12-month period, providing review of IOBT financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
PFE
27.37
+1.05%
PDSB
1.01
0.00%
MRK
89.19
-0.42%
BOLD
1.22
+0.83%
What is IOBT current stock price?
What are IOBT stock strengths?
What risks are associated with IOBT stock?
When is IOBT next earnings report?
What is IOBT market cap and volume?
What is IOBT's current Stock IQ?
Should I buy IOBT stock right now?
Is IOBT a Strong Buy right now?
What does a 'Strong Buy' rating mean for IOBT?
What does a 'Strong Sell' rating mean for IOBT?
What factors influence IOBT's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-6.72%
+35.16%
+1.40%
+4.07%
+0.45%
IOBT
IO Biotech
Current Price
$0.48
Stock Insights
Strengths
Earnings are forecast to grow
Linked to IOBT
PFE
27.37
+1.05%
PDSB
1.01
0.00%
MRK
89.19
-0.42%
BOLD
1.22
+0.83%
Login to unlock IO Biotech (IOBT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$1.8 (-73.33%)
$1.7 (-71.76%)
$1 (-52.00%)
$1.23 (-60.98%)
IOBT Analysts Opinion
IOBT Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Loss widens YoY
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
IOBT Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
IOBT Street view is extremely bullish and have positive views on the near-term outlook
IOBT has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Price under $5
High volatilty
Average key support and resistance price levels.
Login to displayIOBT Earnings
The TTM data reflects the most recent 12-month period, providing overview of IOBT financial performance.
IOBT Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
IOBT Latest Analysis
TGF-β Inhibitors Clinical Trial Pipeline Accelerates as 25 Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight. TGF-β Inhibitors Clinical Trial Pipeline Accelerates as 25 Pharma Companies Rigorously Develop Drugs for Market Entry |. DelveInsight The TGF-β inhibitors market is gaining momentum due to their ability to address significant unmet needs in oncology and fibrosis where existing therapies often show limited effectiveness. The market is expected to surge with the
Tue Sep 23, 2025
IO Biotech Announces Late-Breaking Abstract in Advanced Melanoma Selected for Oral Presentation at ESMO Congress 2025. IO Biotech Announces Late-Breaking Abstract in Advanced Melanoma Selected for Oral Presentation at ESMO Congress 2025
Tue Sep 23, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
IOBT Stock trends
IOBT Stock performance
IOBT Stock analysis
IOBT investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings